Pharmaceutical / Drug Definition :
Inhibits cholesterol absorption in intestine, decreasing intestinal delivery of cholesterol to liver and increasing systemic cholesterol clearance. Net effect is decreased serum cholesterol level.
In the United States, Ezetimibe is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Ezetimibe.
Registrar Corp assists Ezetimibe companies with:
FDA Label Requirements and Exceptions
FDA Import Information
Ezetimibe (Ezetimibe Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Ezetimibe (Ezetimibe Suppliers)
- Processors Ezetimibe
- Repackers Ezetimibe
- Relabelers Ezetimibe
- Exporters Ezetimibe
- Importers Ezetimibe
For more information about Ezetimibe, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.